Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2026 Jan 8;134(2):355. doi: 10.1038/s41416-025-03337-2

Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours

T Gelardi 1, V Damiano 1, R Rosa 1, R Bianco 1, R Cozzolino 2, G Tortora 1, P Laccetti 2, G D’Alessio 2, C De Lorenzo 2,
PMCID: PMC12820155  PMID: 41507566

Editorial Expression of Concern to: British Journal of Cancer 10.1038/sj.bjc.6605499, published online 05 January 2010

The Editor-in-Chief would like to alert the readers that concerns have been raised regarding the images presented in Fig. 3 of this article, specifically:

  • Fig. 3C, pAKT, Erb-hcAb and Erb-hRNase seem to be highly similar to one another

  • Fig. 3C, Actin and Fig. 2C, Actin [1] appear to be highly similar

The authors had been given the opportunity to address the concerns raised; however, they did not respond to the Publisher’s correspondence about this Editorial Expression of concern.

Readers are therefore advised to interpret these results with caution.

References

  • 1.Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, et al. RETRACTED ARTICLE: Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer. 2013;109:686–93. 10.1038/bjc.2013.360. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES